Acromegaly: The significance of serum total and free IGF-I and IGF- binding protein-3 in diagnosis

Journal of Endocrinology

Volumn 155, Issue SUPPL. 1, 1997, Pages

  Van Der Lely, A J ^a   De Herder, W W ^a   Janssen, J A M J L ^a   Lamberts, S W J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ACROMEGALY; ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HORMONE BLOOD LEVEL; HORMONE DETERMINATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN DETERMINATION; SCREENING;

ACROMEGALY; AGING; BIOLOGICAL MARKERS; FEMALE; GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED;

EID: 0030826920     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Barkan AL, Beitins IZ & Kelch RP 1988 Plasma insulin-like growth factor-I/somatomedin-C in acromegaly: correlation with the degree of growth hormone hypersecretion. Journal of Clinical Endocrinology and Metabolism 67 69-73.
2. Baxter RC 1994 Insulin-like growth factor binding proteins in the human circulation: a review. Hormone Research 42 140-144.
3. van den Berg G, Frolich M, Veldhuis JD & Roelfsema F 1994 Growth hormone secretion in recently operated acromegalic patients. Journal of Clinical Endocrinology and Metabolism 79 1706-1715.
4. Clemmons DR, Van Wijk JJ, Ridgway EC, Kliman B, Kjellberg RN & Underwood LE 1979 Evaluation of acromegaly by radioimmunoassay of somatostatin-C. New England Journal of Medicine 301 1138-1142.
5. Dobrashisn RD, O'Halloran DJ, Hunt A, Beardwell CG & Shalet SM 1993 Relationships between insulin-like growth factor-1 levels and growth hormone concentrations during diurnal profiles and following oral glucose in acromegaly. Clinical Endocrinology 38 589-593.
6. Frystyk J, Skjaerbaek C, Dinesen B & Orskov H 1994 Free insulin-like growth factors (IGF-I and IGF-II) in human serum. FEBS Letters 348 185-191.
7. Grinspoon S, Clemmons D, Swearingen B & Klibanski A 1995 Serum insulin-like growth factor-binding protein-3 levels in the diagnosis of acromegaly. Journal of Clinical Endocrinology and Metabolism 80 927-932.
8. de Herder WW, van der Lely AJ, Janssen JA, Uitterlinden P, Hofland LJ & Lamberts SW 1995 IGFBP-3 is a poor parameter for assessment of clinical activity in acromegaly. Clinical Endocrinology 43 501-505.
9. Ho KY & Weissberger AJ 1994 Characterization of 24-hour growth hormone secretion in acromegaly: implications for diagnosis and therapy. Clinical Endocrinology 41 75-83.
10. van der Lely AJ, Harris AG & Lamberts SW 1992 The sensitivity of growth hormone secretion to medical treatment in acromegalic patients: influence of age and sex. Clinical Endocrinology 37 181-185.
11. Melmed S 1990 Acromegaly. New England Journal of Medicine 322 966-977.
12. Melmed S, Ho K, Klibanski A, Reichlin S & Thorner M 1995 Recent advances in pathogenesis, diagnosis, and management of acromegaly. Journal of Clinical Endocrinology and Metabolism 80 3395-3402.
13. Mohan S, Baylink DJ & Pettis JL 1996 Insulin-like growth factor (IGF)-binding proteins in serum: Do they have additional roles besides modulating the endocrine IGF actions? Journal of Clinical Endocrinology and Metabolism 81 3817-3820.